retatrutide triple agonist glp-1 gip glucagon phase 2 nejm 2023 Dual and Gut Peptide Agonists on the Horizon for the Treatment of Type Diabetes and Obesity. An Overview of Preclinical and Clinical Data | Current Obesity Reports 𝗧𝗵𝗲 𝗘𝗳𝗳𝗲𝗰𝘁 𝗼𝗳 𝗚𝗟𝗣-𝟭 𝗥𝗲𝗰𝗲𝗽𝘁𝗼𝗿

Prior authorization costs practices 12-13 staff hours per physician per week (AMA 2024)

Open communication with your healthcare team is key to maximizing the benefits of liraglutide

Gastrointestinal Obstruction and Ileus The FDA issued a new warning about Ozempic in October 2023 after receiving complaints from patients taking the drug

While clinical studies did not find a significant impact on absorption, it is still a good idea to ask your healthcare provider if you should adjust the timing of any medications

Your P3 Clinician will analyze this information and cover it with you in-depth, including recommendations for appropriate interventions